The pandemic had infected at least 109 million people worldwide, causing over 2.4 million deaths as of mid-February. Global needs for the vaccine now greatly exceed available supply.
Vaccine developers’ refusal to share publicly funded vaccine research findings is stalling broader, affordable vaccinations which would more rapidly contain COVID-19 contagion. Avoidable delays in preventive vaccination are imposing terrible burdens on the world economy and human welfare, with economic disruption demanding more relief and recovery measures. By the end of 2021, total global capacity of the 13 leading COVID-19 vaccine manufacturers would still be well short of the needs of the world’s almost 7.7 billion people. Even if they all produce at maximum capacity, a fifth of the world’s population would not have access until 2022.